The group's principal activity is to manage risks by answering critical health questions about disease and therapeutic intervention with advanced immunodiagnostic products. The group's services include Erenna(TM) Technology Access Program, Erenna(TM) Immunoassay Menu and custom assay services. The group operates from the United States.